Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Timothy Holt

Orthopaedic Surgery of the Spine Montgomery, AL Medical Doctor

NPI 1689723868 CMS profile 167769

2065 E South Blvd Ste 204, Montgomery, AL 36116

Open in the dashboard

General payments

$477,920

1,116 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Timothy Holt of Montgomery, AL is reported in the CMS Open Payments database as having received $477,920 across 1,116 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $53,634 92
2024 General $96,396 181
2023 General $83,874 173
2022 General $78,537 196
2021 General $69,227 200
2020 General $24,297 120
2019 General $71,956 154

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Timothy Holt
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Timothy Holt were reported at $53,634. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Timothy Holt Orthopaedic Surgery of the Spine median Middle half National median
2019 $71,956 $2,106 $337–$18,608 $163
2020 $24,297 $1,213 $156–$15,082 $114
2021 $69,227 $1,834 $271–$15,617 $132
2022 $78,537 $2,015 $320–$17,036 $149
2023 $83,874 $1,925 $336–$14,599 $160
2024 $96,396 $2,110 $341–$12,483 $164
2025 $53,634 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. SI-BONE, Inc. $435,666 676 payments
  2. Medtronic, Inc. $8,822 94 payments
  3. Kuros Biosciences USA, Inc $8,324 10 payments
  4. NuVasive, Inc. $5,129 62 payments
  5. Medtronic USA, Inc. $4,351 104 payments
  6. Cerapedics, Inc. $3,935 10 payments
  7. Globus Medical, Inc. $2,262 22 payments
  8. Boston Scientific Corporation $1,825 45 payments
  9. Integrity Implants Inc $1,551 12 payments
  10. Spineology Inc. $1,188 3 payments
  11. Other $4,868 78 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $380,950 253 payments
  2. Travel and Lodging $67,336 300 payments
  3. Food and Beverage $28,070 556 payments
  4. Honoraria $1,500 1 payment
  5. Education $65 6 payments
Products named General payments · program years 2019–2025
  1. IFUSE IMPLANT $218,007 332 payments
  2. IFUSE IMPLANT SYSTEM sacroiliac joint dysfunction $134,181 175 payments
  3. IFUSE IMPLANT SYSTEM sacroiliac joint dysfunction $78,098 95 payments
  4. MAGNETOS $8,163 9 payments
  5. I-FACTOR PEPTIDE ENHANCED BONE GRAFT Peptide Enhanced Bone Graft $3,935 10 payments
  6. I-FACTOR PEPTIDE ENHANCED BONE GRAFT Peptide Enhanced Bone Graft $3,935 10 payments
  7. I-FACTOR PEPTIDE ENHANCED BONE GRAFT Peptide Enhanced Bone Graft $3,935 10 payments
  8. Traverse $2,687 12 payments
  9. MazorX - Renaissance $2,556 49 payments
  10. CD HORIZON SPINAL SYSTEM $2,369 15 payments
  11. Other $22,150 338 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 19 drugs

Part D claims

1,137

Median for Orthopedic Surgery: 203

Drug cost

$20,978

Median for Orthopedic Surgery: $1,433

Branded share of claims

36.4%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Clobetasol Propionate Generic 24 $4,893
Halobetasol Propionate Generic 21 $4,232
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 356 $3,700
Eliquis Apixaban Brand 11 $3,105
Tizanidine Hcl Generic 367 $1,589
Gabapentin Generic 71 $1,042
Celecoxib Generic 14 $401
Cephalexin Generic 43 $273
Methylprednisolone Generic 29 $262
Ropinirole Hcl Generic 17 $248

The 10 drugs with the highest cost, of 19 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 55 billing codes

Paid by Medicare

$143,192

Medicare's payments for the services billed

Medicare patients

179

Average age 70

Services billed

1,024

107 women, 72 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 42%
Chronic kidney disease 35%
Ischemic heart disease 32%
Depression 32%
COPD 25%
Heart failure 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

1,116 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in Alabama

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record